"It's just beautiful seeing them together," Tamika Felder tells PEOPLE of the relationship her son has with his biological ...

COPENHAGEN, Denmark, March 12, 2026 (GLOBE NEWSWIRE) -- Cbio A/S today announced that it has received regulatory clearance to begin a first-in-human Phase I/IIa clinical trial of novoleucel, the ...

Women who overcome cervical cancer might have another potentially life-threatening health crisis on their horizon, researchers say. Cervical cancer survivors have nearly double the risk of developing ...

A three-time survivor shares why persistent symptoms, second opinions and mental health support matter after cervical cancer. Three-time cervical cancer survivor Samantha Gonzales-Russell is ...

NEW YORK (PIX11) — To recognize cervical cancer awareness month, Mr. G met with a Northwell Health gynecologist about the preventable and curable disease. He also had the chance to speak with a ...

After months of severe bleeding and pain, 39-year-old Gemma Doherty learned she had a ...

Anal cancer risk in older cervical cancer survivors exceeded screening thresholds. The incidence of anal cancer reached 17.6 cases per 100,000 person-years among women ages 65 to 74 with a history of ...

Dr. Carrie Frederick can think of many instances over her 14 years in practice in Oregon when patients tried to negotiate their way out of diagnostic testing for cervical cancer because of the ...

Long-term results from a phase 2 study presented at the 27th European Congress on Gynaecological Oncology (ESGO 2026) in Hong ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II study (COMPASSION-03/AK104-201) of ...

Research has increasingly shown that HPV testing is more effective than cytology at detecting cervical precancer. A cohort study showed that patients who tested HPV negative had the lowest cumulative ...

Genmab's recently approved therapy for cervical cancer that has come back or spread, Tivdak, has been turned down for NHS use in initial guidance from reimbursement authority NICE. Tivdak (tisotumab ...